65.4K
Downloads
291
Episodes
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
Episodes
Thursday Aug 06, 2020
Thursday Aug 06, 2020
It is an exciting time in terms of therapeutic progress for myeloproliferative neoplasms (MPN). In recent years, there have been significant advances in the understanding of MPNs, including underlying genetic changes that drive the development of MPNs. This has led to research focusing on targeted therapy and increased the availability of new treatment options.
In this podcast, Srdan Verstovsek, MD, PhD, of the University of Texas MD Anderson Cancer Center, Houston, TX, Claire Harrison, MD, DM, FRCP, FRCPath, of Guy’s and St Thomas’ NHS Foundation Trust, London, UK, and Abdulraheem Yacoub, MD, of the University of Kansas Medical Center, Kansas City, MO, discuss key updates in the treatment and management of MPNs from this year’s European Hematology Association (EHA) 2020 congress.
Friday Jul 31, 2020
Friday Jul 31, 2020
A remarkable increase in the understanding of the pathogenesis of chronic lymphocytic leukemia (CLL) has led to the development of innovative therapies which has generated rapid progress in the management of CLL.
In this podcast, John Gribben of Barts Cancer Institute, London, UK, chairs an insightful discussion with Barbara Eichhorst of the University of Cologne, Cologne, Germany, Susan O’Brien of the University of California, Irvine, CA, and Matthew Davids of Dana-Farber Cancer Institute, Boston, MA, on the latest CLL updates from the recent Virtual ASCO and EHA 2020 Meetings. The speakers discuss frontline therapy for CLL, BTK inhibitors, novel combination therapies and the importance of measurable residual disease (MRD) assessment. Treatment sequencing and novel therapies, in particular CAR T-cell approaches were also discussed.
Tuesday Jul 28, 2020
Tuesday Jul 28, 2020
The ongoing COVID-19 pandemic caused by SARS-CoV-2 is an international public health issue and patients with cancer consistently demonstrate poorer...
The post The HemOnc & COVID-19 Sessions: treating hematological malignancies, reducing nosocomial COVID-19 infections, clinical trial participation and resource allocation appeared first on VJHemOnc.
Thursday Jul 16, 2020
Thursday Jul 16, 2020
The acute myeloid leukemia (AML) field has witnessed rapid evolution of late, with exciting developments in strategies for the treatment...
The post The AML Sessions: emerging immunotherapies, venetoclax-based regimens and targeted therapies in AML appeared first on VJHemOnc.
Tuesday Jul 07, 2020
Tuesday Jul 07, 2020
Acute lymphoblastic leukemia (ALL) is a malignant disorder of lymphoid progenitor cells affecting both adults and children. With a greater...
The post Key updates in ALL at EHA 2020 appeared first on VJHemOnc.
Friday Jul 03, 2020
Friday Jul 03, 2020
The multiple myeloma field is rapidly evolving, with exciting developments in strategies for the treatment of smoldering myeloma, relapsed/refractory (R/R)...
The post The Myeloma Sessions: smoldering myeloma, MRD evaluation, R/R disease & transplant-eligible patients appeared first on VJHemOnc.
Tuesday Jun 02, 2020
Tuesday Jun 02, 2020
Systemic mastocytosis (SM) is a rare hematological neoplasm. Advanced systemic mastocytosis can be sub-classified into either aggressive SM, SM with...
The post Systemic mastocytosis: current landscape, novel agents and COVID-19 appeared first on VJHemOnc.
Wednesday Apr 22, 2020
Wednesday Apr 22, 2020
Assessment of treatment efficacy in acute myeloid leukemia (AML) is highly relevant for further treatment stratification. In clinical trials, measurable...
The post MRD assessment in AML: incorporation into clinical practice appeared first on VJHemOnc.
Tuesday Apr 14, 2020
Tuesday Apr 14, 2020
The management of multiple myeloma presents many clinical challenges. The additional layer of complication COVID-19 places on patients and clinicians...
The post Myeloma management in the COVID-19 era appeared first on VJHemOnc.
Thursday Apr 02, 2020
Thursday Apr 02, 2020
Novel combinations work well for many patients suffering from chronic lymphocytic leukemia (CLL), but there is a subset of patients...
The post CAR-T in the CLL space appeared first on VJHemOnc.